Home・Aktien・Haemonetics Corp

Haemonetics Corp

Open

BrancheGesundheitswesen

107.87 -0.39

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

106.69

Max

108.62

Schlüsselkennzahlen
By Trading Economics
Einkommen	53M 33M
Verkäufe	-7M 339M
KGV Branchendurchschnitt	43.82 57.371
EPS	1.14
Gewinnspanne	9.727
Angestellte	3,009
EBITDA	70M 75M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	-5.55% downside

Dividenden
By Acuity
Nächstes Ergebnis	5. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	163M 4.1B
Vorheriger Eröffnungskurs	108.26
Vorheriger Schlusskurs	107.87

Nachrichtenstimmung

By Acuity

100%

326 / 340 Ranking in Healthcare

Haemonetics Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Aug. 2026, 19:46 UTC

Haemonetics Corp shares are lower today amid rising oil prices and geopolitical tensions. The stock rebounded earlier but has since declined in routine fluctuations.

21. Aug. 2026, 23:01 UTC

Haemonetics Corp is modestly higher in after-market trading, maintaining strength above its 20-day moving average and nearing the upper end of its one-month range.

20. Aug. 2026, 23:01 UTC

Haemonetics Corp shares are higher in after-market hours, nearing the top of their one-month trading range and above the 20-day moving average.

19. Aug. 2026, 23:41 UTC

Haemonetics Corp shares declined after-market, retracing from earlier gains. The asset remains above its 20-day moving average and near the upper end of its one-month range.

18. Aug. 2026, 23:42 UTC

Haemonetics Corp shares are trading lower in after-market hours, reflecting a decline from earlier highs, though remaining above the 20-day moving average.

17. Aug. 2026, 20:06 UTC

Haemonetics Corp shares are lower today, reflecting broader market pressures amid a notable drop in U.S. retail sales for July.

14. Aug. 2026, 19:51 UTC

Haemonetics Corp shares are higher today, supported by a positive trend in the Health Care Supplies sector and increased trading volume.

13. Aug. 2026, 19:51 UTC

Haemonetics shares are declining amid rising jobless claims and flat Producer Price Index data, breaking a recent trend of higher daily closes.

12. Aug. 2026, 20:01 UTC

Haemonetics Corp shares are higher today, supported by unusually high trading volume and a strong upward trajectory since Tuesday's close.

11. Aug. 2026, 20:06 UTC

Haemonetics Corp shares are higher today, maintaining a position near the upper end of their one-month range despite a minor pullback earlier in the session.

10. Aug. 2026, 19:46 UTC

Haemonetics Corp shares are declining amid broader market uncertainty following recent U.S. employment data, despite earlier gains during the session.

7. Aug. 2026, 22:01 UTC

News

Haemonetics shares are lower in after-market trading despite Citigroup raising its price target to $92 and maintaining a Neutral rating.

6. Aug. 2026, 21:01 UTC

Haemonetics Corp. shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

5. Aug. 2026, 19:31 UTC

Haemonetics Corp shares are lower today, breaking a trend of higher closes. The stock is experiencing unusually high trading volume amid no specific news.

4. Aug. 2026, 21:01 UTC

Haemonetics Corp shares declined in after-market hours, despite broader market gains from positive U.S.-Iran negotiations and falling crude oil prices.

3. Aug. 2026, 19:56 UTC

Haemonetics Corp shares are higher, reflecting broader market gains amid positive momentum in major tech stocks and easing geopolitical tensions.

31. Juli 2026, 20:04 UTC

Haemonetics Corp shares are higher, with no specific news identified. The broader market has also gained since Thursday's close, recovering from earlier losses.

30. Juli 2026, 19:48 UTC

Haemonetics Corp. shares are lower today, continuing a decline since Wednesday. The stock remains above its 20-day moving average despite recent downward movement.

29. Juli 2026, 21:21 UTC

Haemonetics Corp shares are lower in after-market trading, reflecting broader declines in the equity market and Health Care Supplies sector amid rising oil prices.

28. Juli 2026, 21:01 UTC

Haemonetics Corp shares are lower in after-market hours, following a broader market decline amid a significant drop in the Nikkei 225 Index.

27. Juli 2026, 22:51 UTC

Haemonetics Corp shares are higher in after-market trading, supported by falling crude oil prices and strong performance above the 20-day moving average.

24. Juli 2026, 20:31 UTC

Haemonetics Corp shares are lower in after-market hours, continuing a decline from Friday's close. No specific news was identified to explain the movement.

23. Juli 2026, 23:21 UTC

Haemonetics Corp shares are lower in after-market trading, continuing a decline that began after Thursday's close, reaching the midpoint of their one-month trading range.

22. Juli 2026, 20:13 UTC

Shares of Haemonetics Corp are trading higher in after-market hours, positioned above its 20-day moving average amid broader market volatility and rising crude oil prices.

20. Juli 2026, 18:46 UTC

Haemonetics Corp shares are higher today, continuing gains since Friday's close. The stock reached a session high earlier, though it has pulled back.

Peer-Vergleich

Kursveränderung

Haemonetics Corp Prognose

Kursziel

By TipRanks

-5.55% Nachteil

12-Monats-Prognose

Durchschnitt 102.38 USD -5.55%

Hoch 120 USD

Tief 84 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Haemonetics Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

9 ratings

Buy

Halten

Sell

Basierend auf 9 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Haemonetics Corp – Dist abgegeben haben.

Stimmung

By Acuity

326 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.